Concepedia

Actionable Pharmacogenes

Actionable Pharmacogenes is a pharmacogenomic construct that denotes specific genes harboring genetic variants with established clinical evidence supporting their use in guiding drug selection or dosing decisions to improve therapeutic outcomes.

14

Publications

494

Citations

141

Authors

65

Institutions

Publications per year

2017–2026

13

Parents

Publications

14

Genetic variation among 82 pharmacogenes: The PGRNseq data from the eMERGE network

DR Crosslin, Aniwaa Owusu‐Obeng, John R. Wallace et al. · Clinical Pharmacology & Therapeutics · 2016 · 187 citations · Full text

, , +16

Cost‐Effectiveness of Panel Tests for Multiple Pharmacogenes Associated With Adverse Drug Reactions: An Evaluation Framework

Catrin Plumpton, Munir Pirmohamed, Dyfrig Hughes · Clinical Pharmacology & Therapeutics · 2018 · 41 citations · Full text

, , +16

Repurposing of Diagnostic Whole Exome Sequencing Data of 1,583 Individuals for Clinical Pharmacogenetics

Maaike van der Lee, William G. Allard, Sander Bollen et al. · Clinical Pharmacology & Therapeutics · 2019 · 39 citations · Full text

, , +17

Variation in 100 relevant pharmacogenes among emiratis with insights from understudied populations

Zeina N. Al-Mahayri, George P. Patrinos, Sukanya Wattanapokayakit et al. · Scientific Reports · 2020 · 37 citations · Full text

, , +12

Pharmacogenomics for Drug Dosing in Children: Current Use, Knowledge, and Gaps

Keito Hoshitsuki, Christian A. Fernandez, Jun J. Yang · The Journal of Clinical Pharmacology · 2021 · 29 citations · Full text

, , +17

1–5 of 14

Authors

141

  1. HG
    Henk‐Jan Guchelaar

    Leiden University Medical Center, Netherlands

    2 publications · 52 citations

    2

    h-index

  2. TM
    Taisei Mushiroda

    RIKEN Center for Integrative Medical Sciences, Japan

    1 publications · 37 citations

    1

    h-index

  3. HN
    Humberto Nicolini

    National Institute of Genomic Medicine, Mexico

    1 publications · 21 citations

    1

    h-index

  4. AM
    Aleš Maver

    Ljubljana University Medical Centre, Slovenia

    1 publications · 16 citations

    1

    h-index

  5. AR
    A R Mejia

    Johns Hopkins University, United States

    1 publications · 187 citations

    1

    h-index

1–5 of 141

Institutions

65

  1. PharmacoGenetics (China)

    Hong Kong, China

    2 h-index

    11 publications

    256 citations

  2. Mayo Clinic

    Rochester, United States

    2 h-index

    14 publications

    614 citations

  3. Leiden University Medical Center

    Leiden, The Netherlands

    2 h-index

    11 publications

    403 citations

  4. United Arab Emirates University

    Al Ain, United Arab Emirates

    1 h-index

    3 publications

    111 citations

  5. Boston Children's Museum

    Boston, United States

    1 h-index

    2 publications

    374 citations

  6. Third Xiangya Hospital

    Changsha, China

    1 h-index

    1 publications

    22 citations

  7. Kaiser Permanente Washington Health Research Institute

    Seattle, United States

    1 h-index

    4 publications

    748 citations

  8. Case Western Reserve University

    Cleveland, United States

    1 h-index

    2 publications

    374 citations

1–8 of 65

Venues

  1. Frontiers in Pharmacology

    3 publications · 50 citations

    3

    h-index

  2. Clinical Pharmacology & Therapeutics

    CPT · 3 publications · 267 citations

    3

    h-index

  3. Drug Metabolism and Disposition

    1 publications · 20 citations

    1

    h-index

  4. 1

    h-index

  5. Frontiers in Genetics

    1 publications · 13 citations

    1

    h-index

1–5